Bone Biospy Market In North America, Europe and Asia | Chronic Kidney Disease and Cancer Major Growth Drivers - Forecast till 2023

Market Overview:

Bone biopsy is a procedure in which a sample of bone tissue is taken and observed under the microscope to diagnose various bone disorders such as osteopenia. It is of two types namely, needle biopsy and open biopsy. In needle biopsy, a biopsy needle is used to take the tissue sample. In open biopsy, an incision is made through the skin and the sample is taken. Bone cancer, bone infection or inflammation, chronic kidney disease and osteoporosis are major indications for bone biopsy.
Rising prevalence of cancer and increasing demand for new diagnostic procedures are the major factors driving the growth of the market across the globe. Furthermore, increasing healthcare expenditure and overall growth of healthcare industry also influence the market growth. Splendid research in the field of oncology also boost the market. However, low patient awareness about chronic kidney disease and importance of early diagnosis among the people may restrain the market growth.
According to the World Health Organisation (WHO), cancer was the leading cause of the total number of deaths globally as of 2015 and was responsible for 8.8 million deaths. The most common causal agents identified are cigarettes, cigars, pipes and chewing tobacco. According to the Cancer Research U.K, looking at the lifestyle factors responsible, it has been found that out of 3 diagnosed cases, 1 may be linked to smoking. The Global Bone Biopsy Market is expected to grow at a CAGR of 5.7% during the forecast period.

Get Report Sample Here https://www.marketresearchfuture.com/sample_request/5341

Key Players for Global Bone Biopsy Market:

• C R Bard (U.S.)
• Becton Dickinson and Company (U.S.)
• B. Braun Melsungen AG
• Hologic, Inc. (U.S.)
• Cook Medical (U.S.)
• Devicor Medical Products Inc. (U.S.)
• Argon Medical Inc. (U.S.) and others.

Segments for Global Bone Biopsy Market:

The global bone biopsy market is segmented on the basis of type, indication and end user. On the basis of the component, market is segmented into needle biopsy and open biopsy. On the basis of the application, the market is segmented into bone cancer, bone infection, chronic kidney disease, osteoporosis, and others. On the basis of the end user, the market is segmented into hospital & clinics, surgical centers, diagnostic centers, and others.

Regional Analysis for Global Bone Biopsy Market:

America is the largest market for bone biopsy owing to the rising prevalence of bone cancer and osteoporosis along with other bone disorders, extensive use of diagnostic services in hospitals & surgical centers and increasing importance of early diagnosis of bone cancer. As per the International Osteoporosis Foundation, over 2 million American men have osteoporosis. In women, bone loss can begin at as early as 25 years of age. Most of the American healthcare providers recommend building strong bones before the age of 30, as a best preventive measure for osteoporosis. Additionally, growing emphasis on healthy lifestyle and importance of exercise for good health boost the market growth. According to the Centers for Disease Control and Prevention (2015) in the U.S., 4.9 million adults were diagnosed with kidney disease. Similarly, according to the U.S. National Kidney Foundation (2015), more than 660,000 Americans were treated for kidney failure also called end stage renal disease (ESRD).

Europe is the second largest market owing to the prevalence of osteoporosis, increasing demand for needle bone biopsy devices and innovative healthcare solutions. Additionally, changing population demographics is projected to the affect prevalence of osteoporosis in the European Union (EU).

The market in Asia Pacific is expected to grow rapidly owing to the rising prevalence of osteoporosis in women after menopause. Moreover, women healthcare is gaining roots in Asian countries owing rising prevalence of diseases in women such as osteoporosis, obesity, and diabetes. Japan is the largest market for bone biopsy in Asia Pacific owing to the flourishing growth of healthcare industry and presence of key players in the market.

The Middle East & Africa also show a steady rise in the market owing to comparatively lesser demand for bone biopsy than the developed nations and high emphasis on primary care services. In the Middle East, the market is driven by increasing demand for specialty care services.

Get Discount on Report https://www.marketresearchfuture.com/check-discount/5341

Some Brief Table of Contents of Report:

Chapter 1. Report Prologue

Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations

Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation

Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges

TOC Continued...

Ask to Our Experts @ https://www.marketresearchfuture.com/enquiry/5341

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future
Office No-528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune — 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.